Related Experiment Video
Updated: Jun 28, 2026

Stimulation of Vascular Endothelial Cells Using Neutrophil Extracellular Traps in the Presence of Low-Density Lipoprotein
Published on: August 12, 2025
LDL reduction: how low should we go and is it safe?
1Lipid Research Clinic, 200 Hawkins Drive SE 226 GH, Iowa City, IA 52242, USA. jennifer-g-robinson@uiowa.edu
Insights
High-intensity statin therapy is often needed for aggressive cholesterol reduction. Combining statins with other drugs like ezetimibe is generally safe, but caution is advised with high-dose statin combinations.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
Background:
- Achieving low-density lipoprotein cholesterol (LDL-C) goals is crucial for cardiovascular health.
- High-dose statin therapy or combination treatments are frequently required for effective LDL-C reduction.
Purpose of the Study:
- To evaluate the safety and efficacy of various statin therapy regimens.
- To identify risks associated with combining different lipid-lowering medications with statins.
Main Methods:
- Review of current literature on statin therapy and combination treatments.
- Analysis of safety data regarding myopathy and hepatic toxicity.
Main Results:
- Adding ezetimibe or bile acid sequestrants to statin therapy shows a low risk of myopathy.
- Combining niacin or fenofibrate with moderate-dose statins appears safe.
- The safety of combining niacin or fenofibrate with high-dose statins remains undetermined.
Conclusions:
- High-dose statin or combination statin therapy is essential for many patients to reach LDL-C targets.
- Careful consideration of patient-specific factors predicting muscle and liver toxicity is vital when using high-dose or combination statin regimens.
Abstract:
High-dose statin therapy or combination statin treatment is necessary for most patients to achieve aggressive low-density lipoprotein cholesterol goals. Adding ezetimibe or bile acid sequestrants appears unlikely to increase the risk of myopathy. Although the combination of niacin or fenofibrate with moderate-dose statins appears to be reasonably safe, the safety of combination with high-dose statins has yet to be determined. To enhance patient outcomes, attention must be paid to characteristics that predict muscle and hepatic statin toxicity when considering using high-dose statin or combination statin therapy.
Related Concept Videos
Atherosclerosis III: Management
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Coronary Artery Disease IV: Preventive Measures
Lipids: Dietary Sources and Requirements
Cholesterol: Significance and Regulation
Considering cholesterol and...